Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

NASDAQ:FIVE - Nasdaq - US33829M1018 - Common Stock - Currency: USD

111.93  +2.99 (+2.74%)

After market: 112.05 +0.12 (+0.11%)

Fundamental Rating

5

FIVE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. FIVE has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, FIVE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

FIVE had positive earnings in the past year.
FIVE had a positive operating cash flow in the past year.
In the past 5 years FIVE has always been profitable.
In the past 5 years FIVE always reported a positive cash flow from operatings.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of FIVE (5.84%) is better than 72.73% of its industry peers.
With a decent Return On Equity value of 14.02%, FIVE is doing good in the industry, outperforming 71.07% of the companies in the same industry.
FIVE has a better Return On Invested Capital (6.78%) than 63.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FIVE is below the industry average of 12.74%.
Industry RankSector Rank
ROA 5.84%
ROE 14.02%
ROIC 6.78%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

The Profit Margin of FIVE (6.54%) is better than 81.82% of its industry peers.
FIVE's Profit Margin has declined in the last couple of years.
FIVE's Operating Margin of 8.35% is fine compared to the rest of the industry. FIVE outperforms 78.51% of its industry peers.
FIVE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 34.89%, FIVE is in line with its industry, outperforming 45.45% of the companies in the same industry.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 8.35%
PM (TTM) 6.54%
GM 34.89%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

FIVE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FIVE has less shares outstanding
Compared to 5 years ago, FIVE has less shares outstanding
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.26 indicates that FIVE is not in any danger for bankruptcy at the moment.
FIVE's Altman-Z score of 3.26 is fine compared to the rest of the industry. FIVE outperforms 74.38% of its industry peers.
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.26
ROIC/WACC0.69
WACC9.79%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.79 indicates that FIVE should not have too much problems paying its short term obligations.
FIVE has a Current ratio of 1.79. This is in the better half of the industry: FIVE outperforms 76.03% of its industry peers.
FIVE has a Quick Ratio of 1.79. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FIVE (0.91) is better than 68.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 0.91
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

FIVE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.01%.
FIVE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.07% yearly.
FIVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.91%.
Measured over the past years, FIVE shows a quite strong growth in Revenue. The Revenue has been growing by 15.99% on average per year.
EPS 1Y (TTM)-7.01%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%-4.66%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%3.97%

3.2 Future

The Earnings Per Share is expected to grow by 30.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 16.48% on average over the next years. This is quite good.
EPS Next Y-6.13%
EPS Next 2Y0.33%
EPS Next 3Y4.25%
EPS Next 5Y30.76%
Revenue Next Year12.22%
Revenue Next 2Y10.8%
Revenue Next 3Y10.4%
Revenue Next 5Y16.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

3

4. Valuation

4.1 Price/Earnings Ratio

FIVE is valuated rather expensively with a Price/Earnings ratio of 22.21.
64.46% of the companies in the same industry are more expensive than FIVE, based on the Price/Earnings ratio.
FIVE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.60.
A Price/Forward Earnings ratio of 23.66 indicates a rather expensive valuation of FIVE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of FIVE to the average of the S&P500 Index (22.43), we can say FIVE is valued inline with the index average.
Industry RankSector Rank
PE 22.21
Fwd PE 23.66
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FIVE is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FIVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 57.77
EV/EBITDA 10.73
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

FIVE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.21
EPS Next 2Y0.33%
EPS Next 3Y4.25%

0

5. Dividend

5.1 Amount

FIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (5/20/2025, 8:00:00 PM)

After market: 112.05 +0.12 (+0.11%)

111.93

+2.99 (+2.74%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-19 2025-03-19/amc
Earnings (Next)06-03 2025-06-03
Inst Owners106.51%
Inst Owner Change-0.12%
Ins Owners1.73%
Ins Owner Change7.11%
Market Cap6.16B
Analysts72.41
Price Target101.83 (-9.02%)
Short Float %8.62%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.46%
Min EPS beat(2)1.27%
Max EPS beat(2)145.65%
EPS beat(4)2
Avg EPS beat(4)34.67%
Min EPS beat(4)-6.03%
Max EPS beat(4)145.65%
EPS beat(8)4
Avg EPS beat(8)18.2%
EPS beat(12)5
Avg EPS beat(12)19.61%
EPS beat(16)8
Avg EPS beat(16)19.42%
Revenue beat(2)1
Avg Revenue beat(2)1.22%
Min Revenue beat(2)-1.15%
Max Revenue beat(2)3.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.79%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)3.58%
Revenue beat(8)1
Avg Revenue beat(8)-1.35%
Revenue beat(12)2
Avg Revenue beat(12)-1.28%
Revenue beat(16)4
Avg Revenue beat(16)-0.55%
PT rev (1m)-0.66%
PT rev (3m)-18.35%
EPS NQ rev (1m)35.68%
EPS NQ rev (3m)39.65%
EPS NY rev (1m)4.35%
EPS NY rev (3m)-10.23%
Revenue NQ rev (1m)4.71%
Revenue NQ rev (3m)6.46%
Revenue NY rev (1m)1.19%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 22.21
Fwd PE 23.66
P/S 1.59
P/FCF 57.77
P/OCF 14.31
P/B 3.41
P/tB 3.41
EV/EBITDA 10.73
EPS(TTM)5.04
EY4.5%
EPS(NY)4.73
Fwd EY4.23%
FCF(TTM)1.94
FCFY1.73%
OCF(TTM)7.82
OCFY6.99%
SpS70.42
BVpS32.85
TBVpS32.85
PEG (NY)N/A
PEG (5Y)2.21
Profitability
Industry RankSector Rank
ROA 5.84%
ROE 14.02%
ROCE 9.04%
ROIC 6.78%
ROICexc 7.95%
ROICexgc 7.95%
OM 8.35%
PM (TTM) 6.54%
GM 34.89%
FCFM 2.75%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexcg growth 3Y-24.82%
ROICexcg growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 193.49%
Cap/Sales 8.36%
Interest Coverage 770.99
Cash Conversion 87.66%
Profit Quality 42.05%
Current Ratio 1.79
Quick Ratio 0.91
Altman-Z 3.26
F-Score6
WACC9.79%
ROIC/WACC0.69
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.01%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%-4.66%
EPS Next Y-6.13%
EPS Next 2Y0.33%
EPS Next 3Y4.25%
EPS Next 5Y30.76%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%3.97%
Revenue Next Year12.22%
Revenue Next 2Y10.8%
Revenue Next 3Y10.4%
Revenue Next 5Y16.48%
EBIT growth 1Y-16.01%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year45.77%
EBIT Next 3Y21.65%
EBIT Next 5Y30.4%
FCF growth 1Y-35.19%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y-13.8%
OCF growth 3Y9.51%
OCF growth 5Y18.16%